Agilent Technologies
91 Blue Ravine Rd
Folsom
California
95630
United States
Tel: +1 916-985-7888
Website: https://www.agilent.com/about/workingwa/in...
Email: RM@cielotalent.com
About Agilent Technologies
Premier Laboratory Partner for a Better World
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services, and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us.
Whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals, or food testing, Agilent provides laboratory solutions to meet their full spectrum of needs. We work closely with customers to help address global trends that impact human health and the environment and to anticipate future scientific needs. Our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management.
Customers trust Agilent for solutions that enable insights...for a better world.
558 articles with Agilent Technologies
-
Agilent Laboratory Achieves Green Lab Certification
6/21/2022
Agilent Technologies Inc. (NYSE: A) today announced that the company’s customer demonstration laboratory in Waldbronn, Germany has received the highest level of Green Lab Certification , the gold standard in laboratory sustainability best practices.
-
Agilent Showcases ‘Consistent, Greener, Smarter’ Approach at Analytica 2022
6/16/2022
Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its latest workflows and solutions at Analytica 2022, being held 21 to 24 June 2022 in Munich, Germany.
-
Agilent Wins Multiple 2022 Scientists' Choice Awards at ASMS
6/15/2022
Agilent Technologies Inc. (NYSE: A) announced that it has received three 2022 Scientists’ Choice Awards including Best New Spectroscopy Product of 2021.
-
Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022
6/6/2022
Agilent Technologies Inc. (NYSE: A) today announced new LC/MS and GC/MS quadrupole mass spectrometers which will be on show at the 70th ASMS Conference on Mass Spectrometry and Allied Topics being held June 5 - 9, 2022 in Minneapolis, Minnesota.
-
Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
6/6/2022
Agilent Technologies Inc. (NYSE: A) today announced the release of its MassHunter BioConfirm 12.0 software, which now supports data generated by Agilent high-resolution LC/MS for oligonucleotide purity analysis and sequence confirmation.
-
Agilent to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
6/1/2022
Agilent Technologies Inc. announced the company will participate in the Goldman Sachs 43rd Annual Healthcare Conference on Wednesday, June 15, in Rancho Palos Verdes, California.
-
Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union
6/1/2022
Agilent Technologies Inc. (NYSE: A) today announced that previously CE-IVD marked instruments, kits, and reagents were released as IVDR Class A on May 26, 2022, in compliance with the new EU IVDR regulation.
-
Agilent Announces Collaboration with APC on Real-Time Process Monitoring
5/27/2022
Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd. , in which the companies commit to working towards combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography (LC).
-
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
5/24/2022
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.61 billion for the second quarter ended April 30, 2022, an increase of 5% compared to the second quarter of 2021 and up 7% on a core(1) basis.
-
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
5/10/2022
Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA® (pembrolizumab) may be appropriate.
-
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
4/26/2022
Agilent Technologies Inc. (NYSE: A) today announced that it will release financial results for the second quarter of fiscal year 2022 after the stock market closes on Tuesday, May 24.
-
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
4/8/2022
Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting , being held April 8 - 13, 2022 in New Orleans, Louisiana.
-
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
4/5/2022
Agilent Technologies Inc. (NYSE: A) today announced CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx immunohistochemical assay to extend the use of the test to patients diagnosed with muscle-invasive urothelial carcinoma (MIUC).
-
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
4/5/2022
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma.
-
Agilent Joins AMBIC to Advance Biomanufacturing
4/4/2022
Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC).
-
Agilent Announces the 2022 Darlene Solomon Award Presented to Grenoble Alpes University Hospital Scientist Dr. Federica Fiorini
3/10/2022
Agilent Technologies Inc. announced that the recipient of the 2022 Darlene Solomon Award is Federica Fiorini, Ph.D., a research associate studying metabolomics at the Institute of Biology and Pathology at the Grenoble Alpes University Hospital in France.
-
Singular Genomics Partners with Agilent to Enable the SureSelect Target Enrichment Reagents for the G4 Sequencing Platform
2/28/2022
Singular Genomics Systems, Inc. today announced a partnership with Agilent Technologies ( www.agilent.com ) to validate its NGS Target Enrichment Products, highly sensitive target enrichment panels with either custom or catalog kits, with the G4 sequencing platform.
-
Agilent to Participate at Cowen and Barclays Health Care Conferences
2/24/2022
Agilent Technologies Inc. announced that Bob McMahon, senior vice president and chief financial officer, will participate in Q&A sessions at the Cowen 42nd Annual Health Care Conference and the Barclays Global Health Care Conference.
-
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
2/24/2022
Agilent Technologies Inc. and the University of Vermont announced the establishment of the Agilent Laboratory for Chemical Analysis.
-
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
2/23/2022
Agilent Technologies Inc. (NYSE: A) announced today that researchers from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, collaborated with Agilent experts on a proof-of-concept FTIR-based saliva COVID-19 testing workflow using the Agilent Cary 630 FTIR Spectrometer.